Lanean...
An analysis of common ethical justifications for compassionate use programs for experimental drugs
BACKGROUND: When a new intervention or drug is developed, this has to pass through various phases of clinical testing before it achieves market approval, which can take many years. This raises an issue for drugs which could benefit terminally ill patients. These patients might set their hopes on the...
Gorde:
| Argitaratua izan da: | BMC Med Ethics |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5069844/ https://ncbi.nlm.nih.gov/pubmed/27756370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12910-016-0145-x |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|